The FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice regulations for active pharmaceutical ingredients.
Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.
Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback